National brain tumour research funding needs to increase to £35 million a year
Brain Tumour Research invited to support the Less Survivable Cancers Taskforce
Brain Tumour Research is pleased to have been invited to support The Less Survivable Cancers Taskforce (LSCT) and joins eight other cancer charity and research organisation invitees who have signed up as registered supporters.
Together, the less survivable cancers of the pancreas, lung, stomach, liver, brain and oesophagus make up half of all the deaths from common cancers in the UK but they have an average five-year survival of less than16% due to a legacy of neglect and underfunding. The Taskforce aims to double the survivability of these cancers by 2029.
Alongside Brain Tumour Research the new supporters are Barrett’s Oesophagus UK, brainstrust, Heartburn Cancer UK, Hepatocellular Carcinoma UK, Oesophago-Gastric Cancer Northern Ireland, Ochre and Pancreatic Cancer Action.
Anna Jewell, Chair of the Taskforce said: “On average, the chance of someone surviving for five years after being diagnosed with one of the less survivable cancers is nearly four times lower than it is for people diagnosed with other common cancers. I’m delighted that the Less Survivable Cancers Taskforce has these new supporters who share our belief that through more research, better treatments and earlier diagnosis we can close the deadly cancer gap.”
Our Chief Executive Sue Farrington Smith MBE added: “Collaboration and campaigning is at our core and, having been a part of Cancer 52 (the common voice for rare and less common cancers) for many years, it’s great that we can now add our support to the LSCT as well. We look forward to doing so and together we can inform and transform.”
There will be social media activity about this news and LSCT’s twitter handle is @LessSurvivable with the hashtag being #DeadlyCancerGap
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.